You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Antiemetic Report: Clinical Evidence for Recommendations

ID: GL-C50-09 Oct 2013
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
CCO Drug Formualry, Antiemetic Working Group

Guideline Objective

Cancer Care Ontario last updated their guidance for the management of chemotherapy induced nausea and vomiting (CINV) in adults in April 2010. The Antiemetic Working Group at Cancer Care Ontario reviewed the current literature to update recommendations for the treatment of acute and delayed CINV for all classifications of emetic potential, and updated emetic risk category for each chemotherapy regimen. This 2013 update largely adopts the most recent American Society of Clinical Oncology (ASCO) guidelines.

Intended Guideline Users

Providers (Physicians, Pharmacists, Nurses)

pdf download Full Report (PDF) (605.16 KB)